Michael BremSenior Scientist, Cell Line Development at Cytovance Biologics Inc.
Mike graduated from East Central University in 1999 with a bachelors degree in Biology. Mike started his career with Novazyme Pharmaceuticals out of the University of Oklahoma Health Sciences Center working on lysosomal storage diseases. Novazyme was acquired by Genzyme in 2002 where Mike spent the next 9 years working on cell line development, transient transfections, and enzyme replacement therapy. Mike transitioned to Cytovance in 2011 where he runs the cell line development team as a Senior Scientist.